Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06532370 · ClinicalTrials.gov registry record · NA
Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii
A NA study, sponsored by Queen's Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06532370 is a NA study that is actively recruiting participants, run by Queen's Medical Center. The registered enrollment target is 40 participants.
The verdict
NCT06532370, a NA study, is actively recruiting participants, sponsored by Queen's Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use. The main objectives are to: * Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury * To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program. Participants will: * Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit * Complete Treatment Effectiveness Assessments at 6 and 12-weeks * Engage in a qualitative interview at the end of the CM program
Interventions
- BEHAVIORAL Contingency Managment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06532370
The ClinicalTrials.gov registry entry for NCT06532370 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Queen's Medical Center, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Contingency Managment is the first listed.
NCT06532370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06532370 about?
NCT06532370 is a clinical study titled "Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii". The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use. The main objectives are to: * Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumati...
What is the current status of trial NCT06532370?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-10-10. Estimated completion is 2026-12-30.
What interventions are being tested in trial NCT06532370?
The interventions under investigation include: Contingency Managment (BEHAVIORAL).
Who is sponsoring clinical trial NCT06532370?
This trial is sponsored by Queen's Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.